-
When research institutions and their IRBs work with centralized IRBs, questions arise about which board handles which responsibilities.
-
RB, FDA, IBC, RAC, DSMB just a few of the alphabet soup organizations and regulatory body steps a researcher must go through to get a protocol written, reviewed, and approved. This can lead researchers to burnout dubbed by some at the National Institutes of Health (NIH) as regulatory fatigue syndrome.
-
Working with different central IRBs and using different models has created some confusion for local IRBs.
-
The Association for the Accreditation of Human Research Protection Programs (AAHRPP) is moving in some new directions as Elyse I. Summers, JD, president and chief executive officer, celebrates her first anniversary with the organization.
-
How investigators report serious adverse events (SAEs) can be subject to gray zones. Answers are not always a clear yes or no.
-
-
The American Geriatrics Society has published guidelines on the use of vitamin D supplementation for the prevention of falls in the elderly, but some researchers are not on board with this.
-
Mitochondrial oxidative stress and damage is connected to neuronal cell death and behavioral outcomes after TBI. Antioxidant treatment with the amide form of N-acetylcsyteine, which has central nervous system (CNS) bioavailability, was shown to improve markers of damage and cognitive function in rats when provided by intraperitoneal injection post experimental TBI.
-
This randomized, parallel group study over 12 months found greater weight and cardiovascular risk benefits in obese adults eating a low-carbohydrate diet vs a low-fat diet.
-
A polysaccharide-rich extract of turmeric rhizome provided benefits in people with knee osteoarthritis.